Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$765,000.00
Apr 1, 2017
BRCA1 therapy for heart failure
$7,134,278.81
Apr 1, 2017
Not-for-profit organization or charity
Newcomer Community Development Program
S184849029
Community Connections, Support Services, Information and Orientation, Needs Assessment & Referrals, Indirect
$614,164.00
Mar 29, 2017
New multi-year agreement
$614,164.11
Mar 29, 2017
$550.00
Mar 20, 2017
$300,000.00
Mar 1, 2017
Comprehending epigenomic changes in gene dysregulation and cancer using machine learning
$135,000.00
Mar 1, 2017
In vitro and in vivo functional assessment of neuropsychiatric disease-related synaptic gene mutations
$74,443.00
Mar 1, 2017
Perinatal Use of Immunosuppressant Therapies and Risk of Infections in Mothers and Babies
$100,000.00
Mar 1, 2017
Use of adipose-derived stem cells and hyperbaric oxygen therapy to enhance healing of skin wounds in irradiated tissues
$147,354.00
Mar 1, 2017
A randomized phase II trial of bortezomib-based therapy plus doxycycline vs. bortezomib-based chemotherapy plus standard supportive therapy in cardiac AL amyloidosis